Certain commonly prescribed antidepressants appear to substantially lower the risk of dying among seriously ill COVID-19 patients, a large new study indicates.
For patients with COVID-19, selective serotonin reuptake inhibitors (SSRIs) are associated with a reduced relative risk for mortality, according to a study published online Nov. 15 in JAMA Network Open.